Werbung
Werbung

INM

INM logo

InMed Pharmaceuticals Inc. Common Shares

1.30
USD
Gesponsert
+0.05
+4.16%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

1.30

0.00
+0.23%

INM Ergebnisberichte

Positives Überraschungsverhältnis

INM übertreffen die 2 der letzten 7Schätzungen.

29%

Nächster Bericht

Datum des nächsten Berichts
10. Feb. 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
--
Implizierte Änderung von Q1 26 (Revenue/ EPS)
--
/
--
Implizierte Änderung von Q2 25 (Revenue/ EPS)
--
/
--

InMed Pharmaceuticals Inc. Common Shares earnings per share and revenue

On 06. Nov. 2025, INM reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q1 2026, InMed Pharmaceuticals Inc. Common Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for 10. Feb. 2026.
Based on -- analysts, InMed Pharmaceuticals Inc. Common Shares is expected to report EPS of -- and revenue of -- for Q2 2026.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung